In May 2023 the India National Anti-Doping Agency (INADA) reported an anti-doping rule violation against the bodybuilder Manpreet Singh after his sample tested positive for the prohibited substances Canrenone, Clenbuterol, Stanozolol and Tamoxifen.
Following notification a provisional suspension was ordered. The Athlete filed a statement in his defence and he was heard for the Anti-Doping Disciplinary Panel of India (ADDPI).
The Athlete admitted the violation and stated that he was unaware that these substances were prohibited. He argued that his sports federation had not banned these substances.
The Panel finds that the presence of prohibited substances has been established in the Athlete's sample and accordingly that he committed an anti-doping rule violation. The Panel determines that he had not mentioned these substances on the Doping Control Form and deems that the violation was intentional.
Therefore the Panel decides on 29 September 2023 to impose a 4 year period of ineligibility on the Athlete, starting on the date of the provisional suspension, i.e. on 16 May 2023.
